Danaher (DHR) Total Non-Current Liabilities (2009 - 2026)
Danaher (DHR) posted quarterly Total Non-Current Liabilities of $85.8 billion for Q2 2026, up 12.97% year-over-year from $76.0 billion in Q2 2025, and up 10.09% quarter-over-quarter from $78.0 billion in Q1 2026.
Danaher (DHR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Danaher's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $85.8 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 12.97% year-over-year to $85.8 billion; the TTM figure through Jun 2026 stood at $85.8 billion (up 12.97% YoY), while the FY2025 annual figure was $77.8 billion, up 8.23% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $85.8 billion, up from $78.0 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $85.8 billion in Q2 2026, with the low at $71.8 billion in Q4 2024.
- The 5-year median for Total Non-Current Liabilities is $76.8 billion (2024), against an average of $76.7 billion.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities dropped 8.44% in 2024, then climbed 12.97% in 2026.
- Danaher's Total Non-Current Liabilities stood at $77.9 billion in 2022, then increased by 0.8% to $78.5 billion in 2023, then decreased by 8.44% to $71.8 billion in 2024, then gained by 8.23% to $77.8 billion in 2025, then grew by 10.39% to $85.8 billion in 2026.
- Business Quant data shows DHR's Total Non-Current Liabilities at $85.8 billion in Q2 2026, $78.0 billion in Q1 2026, and $77.8 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 9.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 85.84 Bn |
| Mar 27, 2026 | 77.98 Bn |
| Dec 31, 2025 | 77.76 Bn |
| Sep 26, 2025 | 74.24 Bn |
| Jun 27, 2025 | 75.99 Bn |
| Mar 28, 2025 | 73.48 Bn |
| Dec 31, 2024 | 71.85 Bn |
| Sep 27, 2024 | 74.97 Bn |
| Jun 28, 2024 | 72.91 Bn |
| Mar 29, 2024 | 77.64 Bn |
| Dec 31, 2023 | 78.47 Bn |
| Sep 29, 2023 | 81.30 Bn |
| Jun 30, 2023 | 78.41 Bn |
| Mar 31, 2023 | 78.48 Bn |
| Dec 31, 2022 | 77.85 Bn |
| Sep 30, 2022 | 73.54 Bn |
| Jul 1, 2022 | 74.21 Bn |
| Apr 1, 2022 | 75.68 Bn |
| Dec 31, 2021 | 75.49 Bn |
| Oct 1, 2021 | 74.31 Bn |